MIAMI.- By the end of 2025, it is estimated that there will be some 313,780 new diagnoses of prostate cancer and 35,770 deaths from this disease in the United States, as indicated by the American Cancer Society. Knowing the risk factors and statistics allows men to be prepared and act in time to prevent the disease or face it with the best possible tools.
How common is prostate cancer?
Over the course of a lifetime, an estimated 1 in 8 men in the United States will be diagnosed with prostate cancer, according to data from the American Cancer Society. This makes it the most common solid tumor in men, accounting for about 30% of all male cancers in 2025.
If we look at age-adjusted rates (i.e., correcting for the aging population), the rate of new cases is approximately 120 cases per 100,000 men per year. Most diagnoses are concentrated in older men: around 60% of cases are detected after the age of 65 and the average age at diagnosis is around 67 years.
The number of men living with a diagnosis of prostate cancer is very high. It is estimated that more than 3.3–3.5 million men in the United States have been diagnosed at some point and are still alive, reflecting both the high incidence and improvements in treatments.
A common but often controllable disease
Although many men will never die from this type of cancer, it is still the second leading cause of cancer death in men, after lung cancer.
The mortality rate is around 19.2 deaths per 100,000 men per year, adjusted for age, and the cumulative lifetime risk of dying from prostate cancer is approximately 1 in 44 men.
Furthermore, survival figures show more hope. According to CDC data, about 98% of men with prostate cancer are still alive five years after diagnosis, considering all stages together.
But it must be noted that this survival changes radically depending on when the disease is detected. When the tumor is diagnosed in localized or regional stages, the 5-year relative survival approaches 100%. But when it is detected in a distant or metastatic stage, the 5-year survival drops to around 38%, which underlines the importance of early detection.
That is, in many cases, prostate cancer is potentially controllable if diagnosed early.
Trends: more cases and more advanced disease
Although the incidence of prostate cancer has been decreasing in recent years, recent analyzes show a worrying change in trend. A report from 2025 indicates that the incidence, which had fallen around 6.4% annually between 2007 and 2014, began to increase around 3% per year between 2014 and 2021.
To this we add the increase in advanced or metastatic cases at the time of diagnosis. Regional studies, such as one conducted in California, describe an annual increase of more than 6% in advanced prostate cancer in the last decade, along with a stabilization of mortality after years of decline.
Experts relate these trends to factors such as changes in guidelines that reduced the systematic use of PSA, lack of equitable access to preventive care, and increases in risk factors such as obesity, sedentary lifestyle, and unhealthy diet.
Inequalities: race, ethnicity and territory
Statistics show that prostate cancer does not affect everyone equally.
- African American men in the United States are about 1.7 times more likely to be diagnosed and 2.1 times more likely to die from prostate cancer than white men.
- Approximately 1 in 6 black men will be diagnosed with the disease in their lifetime.
- Among Hispanic/Latino men, the probability of diagnosis is somewhat lower (about 1 in 9) and they generally have lower incidence and mortality rates than non-Hispanic white and black men.
These differences include social determinants of health: access to health insurance, quality of care, cultural and linguistic barriers, distrust in the health system and less access to specialized centers.
What do these numbers mean for men and their families?
The recent increase in cases and advanced disease, along with racial and social inequalities, reveals the importance of acting in time. The figures support three key public health messages:
- Promote informed conversation about check-ups (PSA, physical examination, complementary tests) between doctor and patient, especially after age 50, or earlier if there are risk factors.
- Focus efforts on higher-risk populations, such as African American men and those with a family history, to reduce mortality gaps.
- Strengthen general prevention, from weight control and physical activity to access to urological care.
Behind each number there is a face: parents, siblings, friends, partners. Knowing the statistics should not provoke fear, but rather invite action. We must consult in time, break down taboos about men’s health and demand fairer and more accessible health systems.
